Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02867358Phase 2Completed
A Phase 2 trial of Lianhua Qingwen in influenza, sponsored by Yiling Pharmaceutical. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02867358.